Sofinnova Venture Partners X, L.P.

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 32% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sofinnova Venture Partners X, L.P.'s trades of Vera Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-02-08 2023-02-06
B Purchase
82,578 +16.4%
428.06
US$1,440,308 		82,578 +16.4% 428.06 US$1,440,308
2022-08-15 2022-08-11
B Purchase
99,746 -17.6%
45.20
US$2,031,012 		99,746 -17.6% 45.20 US$2,031,012
2022-02-14 2022-02-10
B Purchase
89,013 +25.9%
435.55
US$1,118,862 		89,013 +25.9% 435.55 US$1,118,862
2022-01-13 2022-01-11
B Purchase
325,000 +6.2%
16.00
US$5,200,000 		325,000 +6.2% 16.00 US$5,200,000
2021-05-18 2021-05-18
B Purchase
727,272 +33.2%
11.00
US$7,999,992 		727,272 +33.2% 11.00 US$7,999,992
2021-02-09 2021-02-09
B Purchase
450,000 +19.5%
20.00
US$9,000,000 		450,000 +19.5% 20.00 US$9,000,000
2020-07-28 2020-07-28
B Purchase
437,500 +27.5%
16.00
US$7,000,000 		437,500 +27.5% 16.00 US$7,000,000
2020-07-01 2020-06-30
US Akouos Inc (AKUS)
B Purchase
58,823 +4.0%
17.00
US$999,991 		58,823 +4.0% 17.00 US$999,991